CL2014001765A1 - Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina. - Google Patents
Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina.Info
- Publication number
- CL2014001765A1 CL2014001765A1 CL2014001765A CL2014001765A CL2014001765A1 CL 2014001765 A1 CL2014001765 A1 CL 2014001765A1 CL 2014001765 A CL2014001765 A CL 2014001765A CL 2014001765 A CL2014001765 A CL 2014001765A CL 2014001765 A1 CL2014001765 A1 CL 2014001765A1
- Authority
- CL
- Chile
- Prior art keywords
- dimethylphenylsulfanyl
- piperazine
- phenyl
- manufacture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- YQNWZWMKLDQSAC-UHFFFAOYSA-N vortioxetine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 YQNWZWMKLDQSAC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201200006 | 2012-01-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001765A1 true CL2014001765A1 (es) | 2014-10-03 |
Family
ID=48744991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001765A CL2014001765A1 (es) | 2012-01-03 | 2014-06-30 | Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9133144B2 (es) |
| EP (1) | EP2800746B1 (es) |
| JP (1) | JP6018644B2 (es) |
| KR (1) | KR102008039B1 (es) |
| CN (1) | CN104011034B (es) |
| AU (1) | AU2012364402B2 (es) |
| BR (1) | BR112014016322B8 (es) |
| CA (1) | CA2860103C (es) |
| CL (1) | CL2014001765A1 (es) |
| CO (1) | CO7000771A2 (es) |
| CY (1) | CY1121629T1 (es) |
| DK (1) | DK2800746T3 (es) |
| HR (1) | HRP20190769T1 (es) |
| IL (1) | IL233093A (es) |
| LT (1) | LT2800746T (es) |
| MX (1) | MX344144B (es) |
| PL (1) | PL2800746T3 (es) |
| RS (1) | RS58683B1 (es) |
| RU (1) | RU2608307C2 (es) |
| SG (1) | SG11201403835UA (es) |
| SI (1) | SI2800746T1 (es) |
| SM (1) | SMT201900248T1 (es) |
| WO (1) | WO2013102573A1 (es) |
| ZA (1) | ZA201404881B (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10414741B2 (en) | 2013-09-30 | 2019-09-17 | Cadila Healthcare Limited | Amorphous vortioxetine and salts thereof |
| EP2878596A1 (en) * | 2013-11-29 | 2015-06-03 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates |
| EP2894154A1 (en) | 2014-01-14 | 2015-07-15 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)aniline intermediates |
| CN103788020B (zh) * | 2014-01-22 | 2015-11-04 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
| CN103788019B (zh) * | 2014-01-22 | 2015-10-07 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
| CN106103418A (zh) | 2014-01-31 | 2016-11-09 | 埃吉斯药物私人有限公司 | 沃替西汀盐的制备方法 |
| EP2930171A1 (en) | 2014-04-07 | 2015-10-14 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate |
| CN104974110A (zh) * | 2014-04-10 | 2015-10-14 | 江苏豪森药业股份有限公司 | 1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪氢溴酸盐的新晶型及其制备方法和用途 |
| CN105254590B (zh) * | 2014-05-09 | 2019-09-03 | 江苏豪森药业集团有限公司 | 沃替西汀氢溴酸盐晶型及其制备方法和用途 |
| WO2015169130A1 (zh) * | 2014-05-09 | 2015-11-12 | 上海科胜药物研发有限公司 | 新的沃替西汀中间体及其合成方法 |
| CN104059030B (zh) * | 2014-05-30 | 2016-05-04 | 镇江圣安医药有限公司 | [(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途 |
| CN104292183B (zh) * | 2014-09-29 | 2016-01-06 | 杨献美 | 一种抗抑郁药物沃替西汀的制备方法 |
| WO2016079751A2 (en) | 2014-11-17 | 2016-05-26 | Megafine Pharma (P) Ltd. | A process for preparation of vortioxetine and polymorphs thereof |
| EP3023417B1 (en) * | 2014-11-21 | 2017-06-28 | Dipharma Francis S.r.l. | Process for the preparation of an antidepressant and the intermediates thereof |
| CN104356092B (zh) * | 2014-11-27 | 2017-03-22 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
| WO2016125191A2 (en) | 2015-02-04 | 2016-08-11 | Mylan Laboratories Limited | Processes for the preparation of vortioxetine hydrobromide |
| AU2016224930A1 (en) | 2015-02-25 | 2017-09-07 | Lupin Limited | Process for the preparation of Vortioxetine |
| CN104650004B (zh) * | 2015-03-06 | 2017-06-06 | 中山万汉制药有限公司 | 一种氢溴酸沃替西汀的制备方法 |
| CN105061364A (zh) * | 2015-08-17 | 2015-11-18 | 河北国龙制药有限公司 | 氢溴酸沃替西汀的制备方法 |
| WO2017029377A1 (en) * | 2015-08-19 | 2017-02-23 | Amneal Pharmaceuticals Company Gmbh | Process for preparation of vortioxetine hydrobromide |
| CN106556663B (zh) * | 2015-09-30 | 2018-05-29 | 成都弘达药业有限公司 | 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪或其盐的检测方法 |
| WO2018002115A1 (en) | 2016-07-01 | 2018-01-04 | H. Lundbeck A/S | Vortioxetine dosing regimes for fast onset of antidepressant effect |
| US10519121B2 (en) | 2016-12-30 | 2019-12-31 | Apicore Us Llc | Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts |
| CN106831652B (zh) * | 2017-01-23 | 2019-01-11 | 齐鲁天和惠世制药有限公司 | 一种沃赛汀的制备方法 |
| CN108017595A (zh) * | 2017-12-20 | 2018-05-11 | 安徽源久源科技有限公司 | 一种1-[2-(2,5-二甲基苯硫基)苯基]哌嗪的制备方法 |
| PT3810582T (pt) | 2018-06-20 | 2024-04-09 | Vio Ag Pharmaceuticals S A | Uma abordagem de ativação de c-h organo-pseudocatalítica em um só recipiente para a preparação de vortioxetina e intermediário de vortioxetina |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| CN109438390A (zh) * | 2018-11-26 | 2019-03-08 | 合肥创新医药技术有限公司 | 一种氢溴酸沃替西汀杂质的合成方法 |
| US12281088B2 (en) | 2020-09-10 | 2025-04-22 | Suzhou Fude Zhaofeng Biochemical Technology Co., Ltd | Process for the synthesis of vortioxetine |
| CN112250642A (zh) * | 2020-10-28 | 2021-01-22 | 合肥亿帆生物制药有限公司 | 一种氢溴酸伏硫西汀杂质标准品的制备方法 |
| CN115368318B (zh) * | 2022-06-22 | 2023-11-03 | 山东辰龙药业有限公司 | 一种伏硫西汀的合成方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07110050A (ja) | 1993-10-13 | 1995-04-25 | Daikin Mfg Co Ltd | 捩じり振動減衰装置 |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| ATE359276T1 (de) * | 2001-12-20 | 2007-05-15 | Lundbeck & Co As H | Aryloxyphenyl und arylsulfanylphenylderivate |
| PL2044043T5 (pl) * | 2006-06-16 | 2022-05-02 | H. Lundbeck A/S | Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych |
| TW201033181A (en) | 2009-02-17 | 2010-09-16 | Lundbeck & Co As H | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
-
2012
- 2012-12-20 RS RS20190553A patent/RS58683B1/sr unknown
- 2012-12-20 SG SG11201403835UA patent/SG11201403835UA/en unknown
- 2012-12-20 CA CA2860103A patent/CA2860103C/en active Active
- 2012-12-20 KR KR1020147018202A patent/KR102008039B1/ko active Active
- 2012-12-20 AU AU2012364402A patent/AU2012364402B2/en active Active
- 2012-12-20 EP EP12815676.7A patent/EP2800746B1/en active Active
- 2012-12-20 CN CN201280065665.XA patent/CN104011034B/zh active Active
- 2012-12-20 MX MX2014008052A patent/MX344144B/es active IP Right Grant
- 2012-12-20 DK DK12815676.7T patent/DK2800746T3/da active
- 2012-12-20 BR BR112014016322A patent/BR112014016322B8/pt active IP Right Grant
- 2012-12-20 US US14/370,322 patent/US9133144B2/en active Active
- 2012-12-20 SM SM20190248T patent/SMT201900248T1/it unknown
- 2012-12-20 SI SI201231600T patent/SI2800746T1/sl unknown
- 2012-12-20 RU RU2014131943A patent/RU2608307C2/ru active
- 2012-12-20 HR HRP20190769TT patent/HRP20190769T1/hr unknown
- 2012-12-20 WO PCT/EP2012/076377 patent/WO2013102573A1/en not_active Ceased
- 2012-12-20 LT LTEP12815676.7T patent/LT2800746T/lt unknown
- 2012-12-20 JP JP2014550676A patent/JP6018644B2/ja active Active
- 2012-12-20 PL PL12815676T patent/PL2800746T3/pl unknown
-
2014
- 2014-06-12 IL IL233093A patent/IL233093A/en active IP Right Grant
- 2014-06-27 CO CO14139608A patent/CO7000771A2/es unknown
- 2014-06-30 CL CL2014001765A patent/CL2014001765A1/es unknown
- 2014-07-02 ZA ZA2014/04881A patent/ZA201404881B/en unknown
-
2019
- 2019-05-07 CY CY20191100483T patent/CY1121629T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014001765A1 (es) | Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina. | |
| HUS2000040I1 (hu) | Fungicid szubsztituált 2-[2.halogénalkil-4-(fenoxi-fenil]-1-[1,2,4]triazol-1-il-etanol vegyületek | |
| DK3686194T3 (da) | 2-(2,4,5-substitueret-anilino)pyrimidinforbindelser | |
| BR112015001201A2 (pt) | compostos anti-infecciosos 5,5-heteroaromáticos. | |
| EP2935214A4 (en) | 1,4-pyridone COMPOUNDS | |
| LT3010910T (lt) | Pirimidindiono junginiai, skirti širdies ligoms | |
| UY34765A (es) | Compuestos novedosos. | |
| SI2981520T1 (sl) | Novi proces za sintezo 1-(2-((2,4-dimetilfenil)tio)fenil)piperazina | |
| BR112014031787A2 (pt) | composição, métodos de substituição e para produção de refrigeração e equipamento de refrigeração. | |
| ME03392B (me) | Prolek derivati (e)-n-meтil-n-( (з-метi lbenzofuran-2-il)meтil)-3-(7 -okso-5 ,6, 7,8-тетrанidr0-1,8-nafтiridin-3-il)akrilamida | |
| CL2015002309A1 (es) | Proceso de fabricacion de vortioxetina. | |
| PT2912030T (pt) | Processo melhorado de fabrico de 5-(2,6-di-4-morfolinil-4- pirimidinil)-4-trifluorometilpiridin-2-amina | |
| CL2014003459A1 (es) | Compuestos fungicidas heterocíclicos. | |
| CL2014002034A1 (es) | Compuestos derivados de isoxazol-fenil-azetidina fenil sustituidos; y compuestos intermediarios. | |
| BR112014028570A2 (pt) | processo para fabricação de compostos de ciclopentilpirimidina hidroxilada. | |
| CL2014002908A1 (es) | Método para la preparación de 2-(2,3-dimetilfenil)-1-propanal y sus usos. | |
| HRP20190229T1 (hr) | Ormar, postupak za izradu ormara | |
| EP2948441A4 (en) | PROCESS FOR PREPARATION OF 1- (4- (4- (3,4-DICHLOR-2-FLUORO-PHENYL AMINO) -7-METHOXYCHINAZOLINE-6-YLOXY) PIPERIDIN-1-YL) PROP-2-EN-1-ON | |
| PL2608789T3 (pl) | Terapeutyczne zastosowania 1-[2-(2,4- dimetylofenylosulfanylo)- fenylo]piperazyny | |
| UY34677A (es) | Imidazopiridazinas sustituidas | |
| BR112012025490A2 (pt) | ''método para produção de 1,5 oebtanodiamina'' | |
| ITTO20110857A1 (it) | Procedimento per la produzione di cicloesanonossina. | |
| HUE043092T2 (hu) | Eljárás l-[2-(2,4-dimetil-fenilszulfanil)-fenil]-piperazin elõállítására | |
| TH1401006705A (th) | วิธีการสำหรับการเตรียม 2-(2,3-ไดเมททิลฟีนิล)-1-โพรพานัล (2-(2,3-dimethylphenyl)-1-propanal) | |
| PL400350A1 (pl) | Sposób wytwarzania R-(-)-2-chloro-1-(2',4'-dichlorofenylo)-etan-1-olu |